-
The Southern Nevada Health District issued the following questions and answers after launching the largest patient look-back effort in history by contacting 40,000 patients potentially exposed to bloodborne pathogens in a Las Vegas endoscopy clinic:
-
An outbreak of hepatitis C virus (HCV) that recently sparked a massive testing effort affecting 40,000 patients in Las Vegas comes as the largest, latest "look-back" in a series of ambulatory care exposures that shows no signs of stopping.
-
Appropriately enough in Las Vegas, the largest patient look-back investigation in history will come down to something akin to a high-stakes bingo game.
-
In response to a hepatitis C virus outbreak in an endoscopy center in Las Vegas, the American Association of Nurse Anesthetists (AANA) in Park Ridge, IL, is reiterating safe needle practices to all of its members.
-
In light of an outbreak of hepatitis C virus that resulted in public health officials advising 40,000 patients to be tested, Dipak Desai, MD, majority owner of the Endoscopy Center of Southern Nevada at 700 Shadow Lane, issued the following statement on March 10, 2008:
-
Disruptive behaviors are a poor prognostic sign in patients with Alzheimer's disease.
-
Wyeth Pharmaceuticals has received approval to market desvenlafaxine for the treatment of depression. The drug is the major active metabolite of venlafaxine (Effexor ). Wyeth has formulated the drug in a once-daily extended-release tablet. It will be marketed under the trade name Pristiq.
-
Lower serum testosterone in men aged 60 and over was associated with increased fracture risk (especially hip and nonvertebral), even after adjusting for other major risk factors for fracture.
-
Neither training in working techniques nor use of lifting equipment appears to prevent back pain or back-related disability.
-
This single center prospective observational study finds that the utility of a routine daily chest x-ray (CXR) for an ICU patient is quite limited. A change in practice to ordering CXR only when clinically indicated did not adversely impact patient outcome but reduced CXR volume and overall costs.
